Aflac stock
Price history
+14.69% over the period1 year: from $112.27 (November 17, 2025) to $128.76 (November 17, 2026), +14.69%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $128.76 |
| October 30, 2026 | $123.89 |
| September 30, 2026 | $111.78 |
| August 31, 2026 | $115.85 |
| July 31, 2026 | $127.48 |
| June 30, 2026 | $117.25 |
| May 29, 2026 | $112.42 |
| April 30, 2026 | $113.67 |
| March 31, 2026 | $109.71 |
| February 27, 2026 | $112.93 |
| January 30, 2026 | $110.95 |
| December 31, 2025 | $110.27 |
| November 28, 2025 | $110.31 |
| November 17, 2025 | $112.27 |
At a glance
The company
Provides supplemental health and life insurance products in Japan and the United States
Latest results
Quarter to September 30, 2026 · EPS $2.43 (estimate $1.80)
Next event
Dividend
TickerLandia's take on Aflac
- Pricier than usual relative to earnings: P/E on the latest fiscal year 19 vs a median of 11 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 19 vs 16 (+13%) in a group of 11.
- Strong point: Profitability (68/100 in its group). Weak point: Growth (10/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−2.67% from the 52-week high
Analysts · 15 analysts
Average target$119.80−6.18% vs. price
Buy 3 · Hold 8 · Sell 4 · Hold
TickerLandia Fingerprint: Aflac
Compared with similar companies: very low risk and very low growth.
Financials and price compared with 32 companies in the insurance - life industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricehigh79
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 16.5 85 Price/sales 3.80 92 P/E (trailing 12 months) 18.6 71 Price/book 2.16 68 Profitabilityhigh68
How much it earns on revenue and capital.
Metric Value Position in group ROA 2.4% 86 ROE 12.2% 42 Operating margin 27.4% 70 Net margin 21.2% 73 Earnings stabilityaverage54
How steady its margins were over the last five annual reports.
Metric Value Position in group Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Margin variabilitycounts in reverse: lower means more earnings stability 3.1% 48 Growthvery low10
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) −3.57% 5 Revenue growth (year over year) −31.00% 15 Earnings growth (year over year) −80.20% 12 Financial strengthdoes not apply to banks and insurers
How well it would weather a hard period: debt, liquidity, interest.
Dividendaverage51
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 37 years 97 Payout ratio 35.2% 40 Dividend yield 2.0% 15 Market momentumstrong65
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +10.22% 74 Relative strength (6 months) +9.20% 62 1-year return +13.73% 52 Distance from 200-day average +9.25% 72 Riskvery low6
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 14.2% 8 Volatility (60 days) 15.9% 2 Beta (1 year) −0.18 7
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Aflac is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Aflac's P/E today is 18.9, above the median of its last 10 fiscal years (10.7; between 6.67 and 16.2 from 2016 to 2025). Aflac's P/E (trailing 12 months): 18.6, +13% against the median of a group of 11 similar companies (16.5).
Compared with 11 similar companies
| Metric | Aflac | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 18.6 | Middle | |
| Forward P/E | 16.5 | High | |
| ROE | 12.2% | Low | |
| Price/book | 2.16 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Aflac. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$4.12B
Latest quarter · Q2 2026
Net income
$825M
Latest quarter · Q2 2026
Quarterly net margin
20.0%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $63.12B
- P/E
- 18.6
- EPS
- $6.85
- Volume
- 1.73M
- Daily trading
- €201.92M
- Dividend yield
- 2.37%
How Aflac is changing
All resultsRevenue fell 5.0% a year on average over the last 5 years
Shares outstanding down 25.3% in 5 years
Returns
Aflac returns with dividends
$1,000 invested in Aflac 5 years ago, on November 17, 2021, would be worth $2,519 today with dividends reinvested: +151.86% in total, +20.29% per year. On price alone it would be $2,262 (+126.21%).
| Period | Aflac | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +8.50% | −3.17% | $1,085 |
| 6 months | +9.31% | +0.11% | $1,093 |
| Year to date | +16.77% | +8.34% | $1,168 |
| 1 year | +17.13% | +11.15% | $1,171 |
| 3 years | +67.01% | +64.30% | $1,670 |
| 5 years | +151.86% | +58.18% | $2,519 |
| 10 years | +345.89% | +239.10% | $4,459 |
Over the last 6 months it has done better than 69% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Aflac: technical analysis
Aflac is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 1.4% below its highest close since January 2, 1990 ($129.55, July 28, 2026).
- Trend
- Upward
- RSI (14 sessions)
- 67
- Between 30 and 70
- vs 200-session average
- +9.25%
Support and resistance
Price areas where Aflac has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$130.71+2.36%2 touches, last on November 5, 2026
- Last price$127.69
- Support$119.05−6.77%5 touches, last on September 16, 2026
- Support$116.44−8.81%2 touches, last on August 20, 2026
- Support$112.84−11.63%3 touches, last on September 10, 2026
Volatility and risk
Over the last year it has often moved in the opposite direction to the S&P 500.
- Beta (1 year) vs S&P 500
- −0.18
- Volatility (60 sessions, annualised)
- 15.9%
- Largest fall in the last year
- −14.18%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Aflac: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Aflac has been April: +4.38% on average, positive in 26 years out of 37. The weakest has been June: −1.21% on average, positive in 15 years out of 37. November, the current month, has been positive in 22 years out of 36 (+2.45% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.50% | +0.88% | 21 of 36 |
| February | −0.02% | +1.78% | 22 of 37 |
| March | +1.95% | +1.57% | 21 of 37 |
| April | +4.38% | +3.61% | 26 of 37 |
| May | +0.81% | +0.69% | 21 of 37 |
| June | −1.21% | −0.83% | 15 of 37 |
| July | +3.57% | +3.33% | 25 of 37 |
| August | −0.74% | +1.16% | 19 of 37 |
| September | +0.95% | +0.91% | 21 of 37 |
| October | +3.63% | +2.54% | 21 of 37 |
| November | +2.45% | +2.24% | 22 of 36 |
| December | +1.83% | +0.36% | 21 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Aflac and its competitors
Aflac Incorporated, based in Columbus, Georgia, has been operating since its founding in 1955. Through its subsidiaries it provides supplemental health and life insurance, with two reporting segments: Aflac Japan, which offers cancer, medical, nursing care, whole life and GIFT policies in Japan, and Aflac U.S., which covers accident, disability, dental, vision, hospital indemnity and life insurance in the United States. Its range also includes hearing, final expense, pet, Medicare supplement and short-term disability products.
- Headquarters
- Columbus, United States
- Employees
- 12,716
- Founded
- 1955
- Chief executive
- Daniel Amos
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| AflacAFL | $63.12B | 12.2% | 18.6 | +9.31% |
| MetLifeMET | $64.51B | 19.9% | 13.3 | +27.22% |
| Great-West LifecoGWO | $58.72B | 14.4% | 19.3 | +21.58% |
| Manulife FinancialMFC | $72.44B | 12.2% | 18.0 | +21.17% |
| Power Corporation of CanadaPOW | $42.83B | 10.2% | 24.1 | +19.31% |
| Prudential FinancialPRU | $40.35B | 12.0% | 10.6 | +20.02% |
Same industry or related industries, similar size. Compare Aflac with its competitors · Full profile
